Denali Therapeutics Inc. reports

Company location: South San Francisco, CA
Fiscal year end: 31 December

Denali Therapeutics Inc. has filed 787 SEC EDGAR filings since 08 Sep 2017

Filter by type:
10-K
10-Q
8-K
SC13G

SEC filing history

Showing 401-425 of 787 matching filings.

Per page

25

Current page

17

8-K File 001-38311

8-K

Filing date: 07 Feb 2022
Reporting date: 07 Feb 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

SC 13G/A File 005-90223

SC 13G/A filing

Filing date: 03 Feb 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-90223

SC 13G/A filing

Filing date: 18 Jan 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 11 Jan 2022
Reporting date: 08 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-38311

8-K

Filing date: 10 Jan 2022
Reporting date: 10 Jan 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4

Filing date: 07 Jan 2022
Reporting date: 05 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 07 Jan 2022
Reporting date: 05 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 07 Jan 2022
Reporting date: 05 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 07 Jan 2022
Reporting date: 05 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 05 Jan 2022
Reporting date: 03 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 05 Jan 2022
Reporting date: 03 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 05 Jan 2022
Reporting date: 03 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 05 Jan 2022
Reporting date: 03 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 30 Dec 2021
Reporting date: 28 Dec 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 08 Dec 2021
Reporting date: 06 Dec 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 08 Dec 2021
Reporting date: 06 Dec 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 03 Dec 2021
Reporting date: 01 Dec 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-38311

8-K

Filing date: 17 Nov 2021
Reporting date: 17 Nov 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4

Filing date: 12 Nov 2021
Reporting date: 10 Nov 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 08 Nov 2021
Reporting date: 04 Nov 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 001-38311

10-Q

Filing date: 04 Nov 2021
Reporting date: 30 Sep 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-38311

8-K

Filing date: 04 Nov 2021
Reporting date: 04 Nov 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4

Filing date: 03 Nov 2021
Reporting date: 01 Nov 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 03 Nov 2021
Reporting date: 01 Nov 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 06 Oct 2021
Reporting date: 04 Oct 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .